阿尔托神经科学 ANRO
$25.16 +$3.29 (+15.04%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $25.03 -0.52%
开盘$22.12
昨收$21.87
当日区间$21.87 – $25.45
成交量617.5K
市值$987.33M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$29.13M-55.9% YoY
净利润-$27.64M-56.1% YoY
摊薄每股收益-$0.65+0.0% YoY
自由现金流-$19.76M-43.4% YoY
经营现金流-$19.76M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-49.2%
资产收益率-40.9%
投入资本回报率-45.1%
流动比率14.85
负债/资产比率13.7%
现金及投资$243.73M
总负债$21.93M
净现金（净负债）$221.80M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $0.00 | $0.00 | – | – | $0.00 |
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $29.13M | $27.14M | $66.36M | $17.06M | $14.95M |
| 销售及管理费用 | $7.02M | $6.84M | $20.75M | $5.06M | $4.43M |
| -管理费用 | $7.02M | $6.84M | $20.75M | $5.06M | $4.43M |
| 研发费用 | $22.11M | $20.29M | $45.62M | $12.00M | $10.53M |
| 营业利润 | -$29.13M | -$27.14M | -$66.36M | -$17.06M | -$14.95M |
| 非经营性利息净收入（支出） | $1.62M | $1.02M | $4.13M | $986,000.00 | $882,000.00 |
| 非经营性利息收入 | $2.11M | $1.56M | $6.60M | $1.56M | $1.53M |
| 非经营性利息支出 | $491,000.00 | $545,000.00 | $2.47M | $575,000.00 | $650,000.00 |
| 其他收入（支出） | -$130,000.00 | -$115,000.00 | -$1.01M | -$113,000.00 | -$112,000.00 |
| 特殊收益（费用） | $0.00 | $0.00 | -$681,000.00 | $0.00 | $0.00 |
| 其他非经营性收入（支出） | -$130,000.00 | -$115,000.00 | -$327,000.00 | -$113,000.00 | -$112,000.00 |
| 税前利润 | -$27.64M | -$26.24M | -$63.24M | -$16.18M | -$14.18M |
| 净利润 | -$27.64M | -$26.24M | -$63.24M | -$16.18M | -$14.18M |
| 持续经营利润 | -$27.64M | -$26.24M | -$63.24M | -$16.18M | -$14.18M |
| 归属母公司净利润 | -$27.64M | -$26.24M | -$63.24M | -$16.18M | -$14.18M |
| 归属普通股股东净利润 | -$27.64M | -$26.24M | -$63.24M | -$16.18M | -$14.18M |
| 基本每股收益 | -$0.65 | -$0.80 | -$2.19 | -$0.45 | -$0.52 |
| 摊薄每股收益 | -$0.65 | -$0.80 | -$2.19 | -$0.45 | -$0.52 |
| -减：其他特殊支出 | – | – | $681,000.00 | $0.00 | – |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $254.07M | $276.26M | $184.69M | $184.69M | $147.01M |
| 流动资产合计 | $247.32M | $269.13M | $177.72M | $177.72M | $139.45M |
| 现金及现金等价物与短期投资 | $243.73M | $263.76M | $176.48M | $176.48M | $137.82M |
| -现金及现金等价物 | $243.73M | $263.76M | $176.48M | $176.48M | $137.82M |
| 预付资产 | $3.59M | $5.36M | $1.23M | $1.23M | $1.63M |
| 非流动资产合计 | $6.75M | $7.13M | $6.97M | $6.97M | $7.56M |
| 固定资产净值 | $5.91M | $6.30M | $6.13M | $6.13M | $6.49M |
| -固定资产原值 | $7.80M | $8.00M | $7.66M | $7.66M | $7.86M |
| -累计折旧 | -$1.89M | -$1.71M | -$1.53M | -$1.53M | -$1.37M |
| 其他非流动资产 | $838,000.00 | $838,000.00 | $838,000.00 | $838,000.00 | $1.07M |
| 负债合计 | $34.82M | $32.89M | $33.55M | $33.55M | $35.45M |
| 流动负债合计 | $16.65M | $13.12M | $11.33M | $11.33M | $9.05M |
| 应付款 | $4.02M | $3.37M | $1.88M | $1.88M | $2.06M |
| -应付账款 | $4.02M | $3.37M | $1.88M | $1.88M | $2.06M |
| 一年内应计费用 | $7.50M | $6.31M | $7.71M | $7.71M | $5.87M |
| 短期债务及融资租赁负债 | $5.13M | $3.44M | $1.74M | $1.74M | $1.12M |
| -一年内到期债务 | $3.77M | $2.14M | $585,000.00 | $585,000.00 | – |
| -一年内到期融资租赁负债 | $1.36M | $1.30M | $1.15M | $1.15M | $1.12M |
| 非流动负债合计 | $18.17M | $19.78M | $22.22M | $22.22M | $26.40M |
| 长期债务及融资租赁负债 | $18.17M | $19.78M | $22.22M | $22.22M | $26.40M |
| -长期债务 | $14.88M | $16.22M | $18.40M | $18.40M | $22.44M |
| -长期融资租赁负债 | $3.28M | $3.56M | $3.82M | $3.82M | $3.97M |
| 股东权益合计 | $219.25M | $243.37M | $151.14M | $151.14M | $111.56M |
| 股东权益 | $219.25M | $243.37M | $151.14M | $151.14M | $111.56M |
| 股本 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| -普通股 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| 资本公积 | $474.74M | $471.22M | $352.75M | $352.75M | $296.99M |
| 留存收益 | -$255.51M | -$227.87M | -$201.63M | -$201.63M | -$185.45M |
| 不影响留存收益的损益 | $17,000.00 | $13,000.00 | $22,000.00 | $22,000.00 | $14,000.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$19.76M | -$27.09M | -$51.77M | -$11.52M | -$9.92M |
| 持续经营经营活动现金流净额 | -$19.76M | -$27.09M | -$51.77M | -$11.52M | -$9.92M |
| 持续经营净利润 | -$27.64M | -$26.24M | -$63.24M | -$16.18M | -$14.18M |
| 持续经营损益 | $0.00 | $9,000.00 | $837,000.00 | $0.00 | $114,000.00 |
| 折旧、折耗与摊销 | $184,000.00 | $184,000.00 | $661,000.00 | $157,000.00 | $164,000.00 |
| 其他非现金项目 | $498,000.00 | $522,000.00 | $1.83M | $463,000.00 | $499,000.00 |
| 营运资金变动 | $3.64M | -$4.39M | $33,000.00 | $2.10M | $1.30M |
| -预付资产变动 | $1.78M | -$4.13M | $101,000.00 | $656,000.00 | $628,000.00 |
| -应付账款及应计费用变动 | $1.86M | -$263,000.00 | -$68,000.00 | $1.44M | $669,000.00 |
| 投资活动现金流净额 | $0.00 | -$556,000.00 | -$24,000.00 | $0.00 | $0.00 |
| 持续经营投资活动现金流净额 | $0.00 | -$556,000.00 | -$24,000.00 | $0.00 | $0.00 |
| 资本支出 | $0.00 | -$556,000.00 | -$24,000.00 | $0.00 | $0.00 |
| 筹资活动现金流 | -$273,000.00 | $114.94M | $60.08M | $50.19M | $153,000.00 |
| 持续经营筹资活动现金流净额 | -$273,000.00 | $114.94M | $60.08M | $50.19M | $153,000.00 |
| 债务发行及偿还净额 | $0.00 | $0.00 | $9.48M | $0.00 | $0.00 |
| 普通股发行净额 | -$348,000.00 | $115.13M | $49.83M | $49.83M | $0.00 |
| 股票期权行使所得 | $75,000.00 | $6,000.00 | $703,000.00 | $352,000.00 | $153,000.00 |
| 期末现金余额 | $244.23M | $264.26M | $176.98M | $176.98M | $138.32M |
| 现金净变动 | -$20.03M | $87.29M | $8.29M | $38.67M | -$9.77M |
| 期初现金余额 | $264.26M | $176.98M | $168.73M | $138.32M | $148.09M |
| 汇率变动影响 | $4,000.00 | -$16,000.00 | -$30,000.00 | -$1,000.00 | -$4,000.00 |
| 自由现金流 | -$19.76M | -$27.65M | -$51.79M | -$11.52M | -$9.92M |
| 其他筹资费用净额 | – | -$190,000.00 | $67,000.00 | $0.00 | $0.00 |
暂无评论——快来第一个聊聊 ANRO。
登录后参与讨论。